Drug maker AbbVie saw great potential in its testosterone replacement therapy AndroGel. The drug has been on the market since 1953 to treat hypogonadism, a condition in which the body does not produce enough of the hormone testosterone due to injury or disease of the pituitary gland, hypothalamus or testes. This can adversely affect sex drive and muscle mass. Low testosterone levels also occur naturally as men age, which likely started to get the minds of profit-seeking drug makers cranking. And then there was Viagra, the erectile dysfunction drug launched in 1998. Within five years it was a blockbuster drug ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.